Altasciences acquires Calvert Laboratories

By The Science Advisory Board staff writers

May 6, 2021 -- Altasciences announced it has acquired Calvert Laboratories, a contract research organization (CRO) with operations in Pennsylvania and North Carolina.

The acquisition increases Altasciences' small molecule expertise, as well as adds pharmacology, ophthalmology, and carcinogenicity efficacy study capabilities to its current preclinical offering, the company reported in a statement.

Altasciences is a CRO that supports steps in early-stage drug development. Michael Recny, PhD, is the outgoing CEO of Calvert Laboratories.


Copyright © 2021 scienceboard.net
 


Email Address:

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.